Navellier & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.74M | Sell |
|
|||||
|
2025
Q1 | $6.07M | Sell |
|
|||||
|
2024
Q4 | $5.94M | Sell |
|
|||||
|
2024
Q3 | $6.66M | Sell |
|
|||||
|
2024
Q2 | $6.02M | Sell |
|
|||||
|
2024
Q1 | $6.46M | Sell |
|
|||||
|
2023
Q4 | $5.74M | Buy |
|
|||||
|
2023
Q3 | $5.47M | Buy |
|
|||||
|
2023
Q2 | $3.95M | Sell |
|
|||||
|
2023
Q1 | $4.72M | Sell |
|
|||||
|
2022
Q4 | $4.81M | Buy |
|
|||||
|
2022
Q3 | $3.69M | Sell |
|
|||||
|
2022
Q2 | $4.25M | Buy |
|
|||||
|
2022
Q1 | $4.34M | Buy |
|
|||||
|
2021
Q4 | $3.42M | Sell |
|
|||||
|
2021
Q3 | $2.76M | Sell |
|
|||||
|
2021
Q2 | $2.94M | Buy |
|
|||||
|
2021
Q1 | $2.68M | Buy |
|
|||||
|
2020
Q4 | $2.65M | Sell |
|
|||||
|
2020
Q3 | $2.25M | Sell |
|
|||||
|
2020
Q2 | $2.63M | Sell |
|
|||||
|
2020
Q1 | $2.04M | Sell |
|
|||||
|
2019
Q4 | $2.65M | Buy |
|
|||||
|
2019
Q3 | $2.24M | Buy |
|
|||||
|
2019
Q2 | $2.06M | Sell |
|
|||||
|
2019
Q1 | $2.3M | Sell |
|
|||||
|
2018
Q4 | $2.71M | Sell |
|
|||||
|
2018
Q3 | $2.82M | Buy |
|
|||||
|
2018
Q2 | $2.75M | Sell |
|
|||||
|
2018
Q1 | $2.84M | Buy |
|
|||||
|
2017
Q4 | $2.75M | Sell |
|
|||||
|
2017
Q3 | $2.98M | Sell |
|
|||||
|
2017
Q2 | $2.45M | Buy |
|
|||||
|
2017
Q1 | $2.13M | Buy |
|
|||||
|
2016
Q4 | $1.74M | Buy |
|
|||||
|
2016
Q3 | $1.44M | Buy |
|
|||||
|
2016
Q2 | $1.05M | Buy |
|
|||||
|
2016
Q1 | $544K | Buy |
|